Lupin Limited Increases Stake in Philippines Subsidiary
Lupin Limited announced that Multicare Pharmaceuticals Philippines, Inc. (MPPI), a subsidiary of Nanomi B.V., has bought back 2,813,811 equity shares from existing shareholders. Nanomi B.V., a wholly owned subsidiary of Lupin Limited, did not participate in the buyback. This transaction has increased Nanomi’s shareholding in MPPI from 51% to 56.28% effective March 30, 2026.MPPI is headquartered in the Philippines and is engaged in the trading, importing, marketing, and distributing of pharmaceutical products and medical devices. As of March 31, 2025, MPPI reported a turnover of PHP 2,096.6 million and a net worth of PHP 1,265.5 million.
The acquisition does not constitute a related party transaction, and no promoter, promoter group, or group companies have an interest in the buyback.
Financial Details of MPPI (as of March 31, 2025)
| Particulars | Details |
|---|---|
| Turnover | PHP 2,096.6 million |
| Net Worth | PHP 1,265.5 million |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.